Minerva Surgical, Inc. provided revenue guidance for the full year 2022. The company expects full year 2022 revenue in the range of $60 million to $63 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | 0.00% | 0.00% | -99.91% |
03/01 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.91% | 8.88K | |
+12.05% | 128B | |
-9.24% | 10.88B | |
+0.29% | 8.76B | |
+36.99% | 5.48B | |
-21.98% | 4.72B | |
+8.02% | 3.43B | |
-10.32% | 2.76B | |
-12.33% | 2.06B | |
-13.53% | 1.92B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Revenue Guidance for the Full Year 2022